Problems › What Is My Business Actually Worth? › Agriculture & Agribusiness
Valuation is mostly a question about how much of the earnings from forward contracts and spot sales will survive a change in ownership, not the size of the total. The version of this question that applies to mixed cropping farms is not the generic one. Forward contracts cover 48 percent of revenue locking prices twelve months ahead while 52 percent spot exposure leaves ebitda vulnerable to price and water volatility — so an answer that ignores 4,800 hectares will be confidently wrong. The analysis has to start from 24.9 percent gross margin and 71 percent packing utilisation rather than from revenue.
Valuation is mostly a question about how much of the earnings from forward contracts and spot sales will survive a change in ownership, not the size of the total. The version of this question that applies to mixed cropping farms is not the generic one. Forward contracts cover 48 percent of revenue locking prices twelve months ahead while 52 percent spot exposure leaves ebitda vulnerable to price and water volatility — so an answer that ignores 4,800 hectares will be confidently wrong. The analysis has to start from 24.9 percent gross margin and 71 percent packing utilisation rather than from revenue.
Operators tend to think about valuation as a multiple applied to profit. Buyers think about it as a judgement on how much of that profit from the 48 percent locked in forward contracts and the 52 percent exposed to the spot market will continue under new ownership — which is why two farms with identical revenue from 4,800 hectares sell for very different numbers.
The drivers are consistent: how much revenue sits in forward contracts versus spot market exposure, how dependent the result is on owner-held groundwater licences, how far packing utilisation sits below full capacity, and whether the gross margin holds once third-party intake volumes change. Each of those moves the multiple more than an incremental point of profit moves the base.
Which means the practical question is usually not "what is it worth" but "which of these is depressing the multiple, and can it be fixed in the time available before a sale".
These three together are the signature. One on its own usually points somewhere else.
✓ The CFO sees the earnings presented without separating the locked-in forward contract contribution from the spot market volatility that actually occurred.
✓ A large share of the margin traces to relationships or licences held personally by the owner rather than by the operating entity.
✓ Weekly or seasonal revenue reports show most of the result still coming from spot sales and third-party intake that must be renegotiated each period.
The move that usually makes it worse. Optimising the gross margin in the year before a sale while leaving the forward-contract coverage, packing utilisation and groundwater licence exposure unchanged, which usually adds less value than fixing one of them.
It is for you if you run or finance a mixed cropping farm and you are within a few years of a transaction and have never had the earnings normalised. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a mixed cropping farm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Halloway Fields Group, a sample company profile used for testing rather than a customer — $51.8 million revenue from 4,800 hectares.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Lock 60 percent of output under CPI-protected supermarket contracts to stabilise EBITDA against input-cost shocks.
| Investment required | $0.2–0.4 million for commercial renegotiation and legal costs; drip-irrigation on the additional 576 hectares is already funded inside the $2.1 million committed irrigation line within the. |
| Expected return | Base case incremental EBITDA of $0.8–1.2 million annually (180–240 bps margin improvement) on the $0.2–0.4 million commercial investment, yielding a 3-year payback and 2.0–3.0x cash-on-cash. |
| Revenue, year 1 | $52.8–53.4 million |
| Revenue, year 2 | $54.1–55.2 million |
| Revenue, year 3 | $55.8–57.1 million |
| Exit criteria | Strategy should be reversed if, within 12 months of CPI-clause implementation, actual input-cost inflation exceeds 30 percent above CPI and supermarkets refuse to honour escalation clauses, OR if contracted volume falls below 55 percent of output due to buyer defection. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For mixed cropping farms it works through 4,800 hectares, 24.9 percent gross margin, 71 percent packing utilisation and 4.1 times interest cover, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Ranges by sector are easy to find and are the least useful part of the answer. Where you land inside the range is decided by concentration, recurrence, owner dependence and margin defensibility.
Two to three years if the aim is to move the multiple, because that is how long recurring revenue and reduced owner dependence take to become visible in the numbers.
It depends on the buyer. Financial buyers pay for durable cash flow; strategic buyers pay for what the business does to their own position. Knowing which you are preparing for changes what to fix.
Materially, yes. Forward contracts cover 48 percent of revenue locking prices twelve months ahead while 52 percent spot exposure leaves ebitda vulnerable to price and water volatility — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 4,800 hectares, 24.9 percent gross margin, 71 percent packing utilisation, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 4,800 hectares and 24.9 percent gross margin. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית